Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 155-167

  Xie, Wei ^a   Wang, Lei ^a   Dai, Qian ^a   Yu, Hua ^a   He, Xiaomei ^a   Xiong, Junzhi ^a   Sheng, Halei ^a   Zhang, Di ^a   Xin, Rong ^a   Qi, Yajuan ^b   Hu, Fuquan ^a   Guo, Shaodong ^b   Zhang, Kebin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

AMPK; Coxsackievirus B3; Lipid accumulation; Myocarditis; Viral replication

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; PALMITIC ACID; ADENYLATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS B3; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RNA INTERFERENCE; SURVIVAL RATE; VIRUS INHIBITION; VIRUS MYOCARDITIS; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; ENTEROVIRUS B; HELA CELL LINE; HUMAN; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

COXSACKIEVIRUS; MUS;

ADENYLATE KINASE; ANIMALS; ENTEROVIRUS B, HUMAN; ENZYME ACTIVATION; HELA CELLS; HUMANS; LIPID METABOLISM; MALE; MICE, INBRED BALB C; MICE, OBESE; VIRUS REPLICATION;

EID: 84930947204     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.05.021     Document Type: Article

References (47)

1. Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 2008, 3:127-155.
2. Harris K.G., Coyne C.B. Death waits for no man - does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev 2014, 25:587-596.
3. Tam P.E. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 2006, 19(2):133-146.
4. Brunetti L., DeSantis E.R. Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm 2008, 65(2):132-137.
5. Shauer A., Gotsman I., Keren A., Zwas D.R., Hellman Y., Durst R., et al. Acute viral myocarditis: current concepts in diagnosis and treatment. Isr Med Assoc J 2013, 15(3):180-185.
6. Henke A., Jarasch N., Wutzler P. Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis. Expert Rev Vaccines 2008, 7(10):1557-1567.
7. Zhang L., Parham N.J., Zhang F., Aasa-Chapman M., Gould E.A., Zhang H. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 2012, 30(13):2301-2308.
8. Lorizate M., Krausslich H.G. Role of lipids in virus replication. Cold Spring Harb Perspect Biol 2011, 3(10):a4820.
9. Limpens R.W., van der Schaar H.M., Kumar D., Koster A.J., Snijder E.J., van Kuppeveld F.J., et al. The transformation of enterovirus replication structures: a three-dimensional study of single- and double-membrane compartments. MBio 2011, 2(5):e00166-11.
10. Richards A.L., Soares-Martins J.A., Riddell G.T., Jackson W.T. Generation of unique poliovirus RNA replication organelles. MBio 2014, 5(2):e00833-13.
11. Wong J., Zhang J., Si X., Gao G., Mao I., McManus B.M., et al. Autophagosome supports coxsackievirus B3 replication in host cells. J Virol 2008, 82(18):9143-9153.
12. Kemball C.C., Alirezaei M., Flynn C.T., Wood M.R., Harkins S., Kiosses W.B., et al. Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo. J Virol 2010, 84(23):12110-12124.
13. Chukkapalli V., Heaton N.S., Randall G. Lipids at the interface of virus-host interactions. Curr Opin Microbiol 2012, 15(4):512-518.
14. Ilnytska O., Santiana M., Hsu N.Y., Du W.L., Chen Y.H., Viktorova E.G., et al. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 2013, 14(3):281-293.
15. Berger K.L., Kelly S.M., Jordan T.X., Tartell M.A., Randall G. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J Virol 2011, 85(17):8870-8883.
16. Wilsky S., Sobotta K., Wiesener N., Pilas J., Althof N., Munder T., et al. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch Virol 2012, 157(2):259-269.
17. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011, 13(9):1016-1023.
18. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13(4):251-262.
19. Moser T.S., Schieffer D., Cherry S. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog 2012, 8(4):e1002661.
20. Mankouri J., Tedbury P.R., Gretton S., Hughes M.E., Griffin S.D., Dallas M.L., et al. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proc Natl Acad Sci U S A 2010, 107(25):11549-11554.
21. McArdle J., Moorman N.J., Munger J. HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog 2012, 8(1):e1002502.
22. Kudchodkar S.B., Del P.G., Maguire T.G., Alwine J.C. AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection. J Virol 2007, 81(7):3649-3651.
23. Rassmann A., Martin U., Saluz H.P., Peter S., Munder T., Henke A. Identification of gene expression profiles in HeLa cells and HepG2 cells infected with Coxsackievirus B3. J Virol Methods 2013, 187(1):190-194.
24. Xie W., Feng Q., Su Y., Dong B., Wu J., Meng L., et al. Transcriptional regulation of PES1 expression by c-Jun in colon cancer. PLoS ONE 2012, 7(7):e42253.
25. Xie W., Qu L., Meng L., Liu C., Wu J., Shou C. PES1 regulates sensitivity of colorectal cancer cells to anticancer drugs. Biochem Biophys Res Commun 2013, 431(3):460-465.
26. Zhang K., Yu H., Xie W., Xu Z., Zhou S., Huang C., et al. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity. J Biotechnol 2013, 164(4):461-468.
27. Lee J.S., Mendez R., Heng H.H., Yang Z.Q., Zhang K. Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation. Am J Transl Res 2012, 4(1):102-113.
28. Zhang K., Li L., Qi Y., Zhu X., Gan B., DePinho R.A., et al. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 2012, 153(2):631-646.
29. Zhang Y.Y., Li J.N., Xia H.H., Zhang S.L., Zhong J., Wu Y.Y., et al. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. Life Sci 2013, 92(24-26):1186-1194.
30. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011, 12(5):408-415.
31. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100(3):328-341.
32. Esfandiarei M., Luo H., Yanagawa B., Suarez A., Dabiri D., Zhang J., et al. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol 2004, 78(8):4289-4298.
33. Pernicova I., Korbonits M. Metformin-mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 2014, 10(3):143-156.
34. Hawley S.A., Ross F.A., Chevtzoff C., Green K.A., Evans A., Fogarty S., et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 2010, 11(6):554-565.
35. Cool B., Zinker B., Chiou W., Kifle L., Cao N., Perham M., et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006, 3(6):403-416.
36. Mankouri J., Harris M. Viruses and the fuel sensor: the emerging link between AMPK and virus replication. Rev Med Virol 2011, 21(4):205-212.
37. Lettieri B.D., Vegliante R., Desideri E., Ciriolo M.R. Managing lipid metabolism in proliferating cells: new perspective for metformin usage in cancer therapy. Biochim Biophys Acta 2014, 1845(2):317-324.
38. Rassmann A., Henke A., Jarasch N., Lottspeich F., Saluz H.P., Munder T. The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases?. Antiviral Res 2007, 76(2):150-158.
39. Guan J., Sun X., Liang Y., Dong W., Zhang L., Zhu J., et al. Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice. J Cardiovasc Pharmacol 2010, 56(5):540-547.
40. Rassmann A., Henke A., Zobawa M., Carlsohn M., Saluz H.P., Grabley S., et al. Proteome alterations in human host cells infected with coxsackievirus B3. J Gen Virol 2006, 87(Pt 9):2631-2638.
41. Jensen K.J., Garmaroudi F.S., Zhang J., Lin J., Boroomand S., Zhang M., et al. An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection. Cell Host Microbe 2013, 13(1):67-76.
42. Luo H., Yanagawa B., Zhang J., Luo Z., Zhang M., Esfandiarei M., et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 2002, 76(7):3365-3373.
43. Schulze K., Witzenbichler B., Christmann C., Schultheiss H.P. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res 1999, 44(1):91-100.
44. Mehla R., Bivalkar-Mehla S., Zhang R., Handy I., Albrecht H., Giri S., et al. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS ONE 2010, 5(6):e11160.
45. Coyne C.B., Bozym R., Morosky S.A., Hanna S.L., Mukherjee A., Tudor M., et al. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 2011, 9(1):70-82.
46. Gaidhu M.P., Fediuc S., Anthony N.M., So M., Mirpourian M., Perry R.L., et al. Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 2009, 50(4):704-715.
47. Targett-Adams P., Boulant S., Douglas M.W., McLauchlan J. Lipid metabolism and HCV infection. Viruses 2010, 2(5):1195-1217.